title: Postmarketing evaluation of drugs. Actual efficacy, population exposed and impact on public health.
abstract: Round table no. 2 was devoted to the postmarketing evaluation of drugs. The debates involved both the questions posed by postmarketing evaluation and the methods for responding to them. The major categories of questions likely to be posed are as follows: efficacy in actual situations; safety in actual situations; prognostic factors and patients responding; place in the therapeutic strategy; impact on the healthcare care system; the 'joined' population (those who actually obtain benefit); and drug utilisation review. In addition, the methodological approaches have been divided into three categories: the experimental approach, the observational approach and the modelling approach. Each of these methodological approaches has been qualified with respect to each of the questions. The objective was neither to establish a classification of the methods according to the level of proof, nor to propose methodological formulae. Instead, the participants applied themselves to describe the strengths and the limits of the different methods for each of the questions in turn. The debates then focused on the process of identification of pertinent questions and appropriate methods. In this context, the round-table participants applied an analysis of the current system of postmarketing study projects and formulated some propositions for their improvement. Finally, the place of existing databases in the postmarketing evaluation was discussed and the participants emphasised the importance of initiating a very detailed assessment of the information that could be provided by such databases before instituting ad hoc studies.
authors.affiliation: INSERM U537/DGS, Paris, France. U537@kb.inserm.fr
authors.forename: Catherine
authors.initials: C
authors.lastname: Le Galès
authors.forename: Abdelkader
authors.initials: A
authors.lastname: el Hasnaoui
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Goehrs
mesh_terms: D016208:Databases, Factual; D064420:Drug-Related Side Effects and Adverse Reactions; D005602:France / Q000453:epidemiology; D006801:Humans; D011153:Population; D011358:Product Surveillance, Postmarketing; D011634:Public Health